Barrio-Real, Lopez-Haber C, Casado-Medrano V, Goglia AG, Toettcher JE, Caloca MJ, and Kazanietz MG. 2018. “P-Rex1 Is Dispensable for Erk Activation and Mitogenesis in Breast Cancer”. Oncotarget 9 (47). Impact Journals, LLC: 28612. Publisher’s Version: P-Rex1 is dispensable for Erk activation and mitogenesis in breast cancer.